期刊文献+

老年难治性抑郁症临床特征分析及一线抗抑郁药临床疗效对比 被引量:9

Clinical Characteristics of Elderly Patients with Treatment Resistant Depression and the Efficacy of Antidepressant
在线阅读 下载PDF
导出
摘要 目的:调查老年难治性抑郁症患者的临床特征并对一线抗抑郁药的临床疗效进行对比分析。方法选择2010.1-2013.12我院住院治疗的60岁以上难治性抑郁症患者80例和20~40岁的非老年普通抑郁患者80例,使用汉密尔顿抑郁量表( HAMD)对两组抑郁特征进行分析对比同时观察TCAs、SSRIs两类主要一线抗抑郁药对老年难治性抑郁患者的临床疗效。结果非老年组与老年组HAMD中激越性抑郁因子、焦虑反应因子无显著差异,老年组躯体症状因子(t=29.85;P<0.01)、迟滞性抑郁因子(t=42.30;P<0.01)与非老年组比较有显著差异;在老年难治性抑郁症治疗效果方面TCAs组治疗各周(1、2、4、8、12)与SSRIs组比较均有显著差异,效果明显优于SSRIs组:(t=8.03,21.40,49.87,48.90,84.81;P<0.01)。结论老年性难治性抑郁症具有其特殊临床特征,一线抗抑郁药物TCAs对老年性难治性抑郁的治疗效果明显优于SSRIs。 Objective To explore the clinical characteristics of elderly patients with treatment resistant depression and compare the efficacy of antidepressant .Methods 80 patients over 60 with treatment resistant depression and 80 normal depressives between 20-40 were measured by HAMD and the efficacy of TCAs and SSRIs were analyzed .Results There were no significant differences between the elderly patients and non -elderly patients in somatization and retarded depression (t=29.85,42.30;P〈0.0).TCAs had better efficacy in 1,2,4,8,12 weeks of treatment in elderly with treatment resistant depression than SSRIs (t=8.03,21.40,49.87,48.90,84.81;P〈0.01).Conclusion Treatment resistant depression in elderly has specific clinical characteristics and TCAs is better than SSRIs in the treatment of elderly with treatment resistant depression .
作者 左潇
出处 《中国健康心理学杂志》 2014年第9期1308-1310,共3页 China Journal of Health Psychology
关键词 难治性抑郁症 老年 临床特征 一线抗抑郁药物 Treatment resistant depression Elderly Clinical characteristics SSRIs
  • 相关文献

参考文献8

二级参考文献70

共引文献272

同被引文献105

  • 1李红燕.盐酸佛西汀联合心理干预对老年糖尿病合并抑郁患者的疗效观察[J].医学信息,2017,30(5):139-140. 被引量:1
  • 2张丽萍.抑郁症治疗中重视调理脾胃气机的作用探讨[J].陕西中医,2005,26(1):45-47. 被引量:66
  • 3陈立新,姚远.老年人心理健康影响因素的调查研究——从人格特征与应对方式二因素分析[J].市场与人口分析,2006,12(2):63-68. 被引量:28
  • 4范珊红,化前珍,马艳,余咏,张美霞,南菁,王线妮,赵艳立.西安市城市社区老年人抑郁症状发生率及危险因素研究[J].护理研究(下旬版),2007,21(2):483-485. 被引量:25
  • 5Djurovic D,Milic Askrabic J,Majkic Singh N.Serum beta-endorphin levels in-patients with depression on fluvoxamine[J].Farmaco,1999,54:130.
  • 6Duval F,Mokrani M C,Monreal Ortiz J A,et al.Cortisolhyperse-cretion in unipolarm ajor dep ress ion w ithm elancholic and p sychoticfeatures;Dopam inerg ic,norad renergic and thyroid correlates[J].Psychoneuroendocrinology,2006,31(7):876-888.
  • 7Nemeroff C B,Simon J S,Haggerty J J,et al.Antithyroid antibodies in depressed patients[J].Am J Psychiatry,1985,142(7):840-843.
  • 8Coplan J D,Smith E L,Altemus M,et al.Variable foraging demand rearing:Sustained elevations in cisternal cerebrospinal fluid corticotropin-releasing factor concentrations in adult primates[J].Biol Psychiatry,2001.50(3):200-204.
  • 9Coplan J D,Andrews M W,Rosenblum L A F,et al.Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factoe in adult nonhuman primates exposed to early-life stressors:Implications for the pathophysiology of mood and anxiety disorders[J].Proc Natl Acad Sci,1996,93(4):1619-1623.
  • 10Eker S S,Akkaya C,Sarandol A,et al.Effects of various antidepressantson serum thyroid hormone levels in patients with major depressive disorder[J].Progress in Neuro-Psychopharmacology and Biological Psychiatry,2008,32:955-961.

引证文献9

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部